Lightwave Logic Perkinamine Indigo Optical Coating Holds Promise for Microelectronics Applications

Lightwave Logic, Inc., a technology company focused on the development of a Next Generation Non Linear Optical Polymer Materials Platform and Optical Devices for applications in high speed fiber-optic data communications and optical computing, announced today that preliminary testing results on devices recently coated with Perkinamine Indigo™ demonstrated several of the key performance parameters desired by our potential microelectronics customer.

The areas tested included film quality, optical throughput, insertion loss, thermal stability, poling signature and electro-optic modulation.

Tom Zelibor , Chairman and Chief Executive Officer of Lightwave Logic commented, "After reviewing the results with our potential customer, we are confident that Perkinamine Indigo™ has several desirable characteristics that give us a competitive advantage. The microelectronics company has expressed similar satisfaction with these results and has requested to use our Perkinamine Indigo™ chromophore with a proprietary host polymer they are evaluating.

"We are very satisfied with these initial results which were in line with several of our own internal tests. While we remain unaware of the specific application, we do know that Perkinamine Indigo™ has passed the first hurdle for many of the requirements. The task at hand for us is to optimize certain engineering aspects by realigning our internal research to work more closely with our potential customer to address this exciting opportunity."

Source: http://www.lightwavelogic.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.